Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02713529
Title Safety Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amgen

lung non-small cell carcinoma

colorectal cancer

pancreatic cancer


AMG 820 + Pembrolizumab

Age Groups: adult
Covered Countries USA | ESP | DEU | CAN | BEL

No variant requirements are available.